We offer streamlined licensing for companies interested in CU technologies. They aim to balance financial return for the university with real-world impact. CU has over 150 exclusive and 200 non-exclusive licenses with industry partners, resulting in FDA-approved drugs and medical devices. Browse through our current technologies.
CU Innovations Flintbox Online Licensing Platform showcases a wide variety of health care technologies available from biological materials, research tools and software to diagnostics, medical devices, and therapeutics.
With a direct link to technologies from CU Anschutz Medical Campus and UC Denver, this is the best place to search for new health care technologies to commercialize. For inquiries or assistance, email the licensing team at cuinnovations@cuanschutz.edu.
CU Innovations aims to meet industry partner needs through a streamlined, collaborative licensing process. CU’s dual goals are to generate a fair financial return for the university, supporting research and incentivizing technology commercialization, and maximizing real-world impact of CU technologies. CU shares commercialization risk by setting reasonable licensing fees and receiving royalties and milestone payments only when products are developed and sold.
CU has exclusive and non-exclusive licenses in effect and has executed 40+ new licenses and options in 2023, with industry partners ranging from new startup companies to multinational pharmaceutical companies. Successful agreements with CU have led to the development of drugs, medical devices and diagnostic technologies.